We are live on ! Find out more
RA

Rise Advisors Portfolio holdings

AUM $355M
1-Year Est. Return 20.51%
This Fund
S&P 500
This Quarter Est. Return
+9.46%
1 Year Est. Return
+20.51%
3 Year Est. Return
+58.86%
5 Year Est. Return
10 Year Est. Return
AUM
$143M
AUM Growth
+$16.9M
Cap. Flow
-$3.81M
Cap. Flow %
-2.67%
Top 10 Hldgs %
72.74%
Holding
677
New
27
Increased
219
Reduced
106
Closed
59

Top Sells

Rank Stock Value
1
VUG icon
Vanguard Growth ETF
VUG
+$7.84M
2
DFCF icon
Dimensional Core Fixed Income ETF
DFCF
+$7.63M
3
AAPL icon
Apple
AAPL
+$2.19M
4
DKNG icon
DraftKings
DKNG
+$478K
5
CSCO icon
Cisco
CSCO
+$154K

Sector Composition

Rank Sector Weight
1 Financials 5.79%
2 Technology 3.21%
3 Consumer Discretionary 2.43%
4 Healthcare 1.85%
5 Industrials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLCH icon
401
Franklin FTSE China ETF
FLCH
$280M
$3.92K ﹤0.01%
244
+5
+2% +$83
JETS icon
402
US Global Jets ETF
JETS
$768M
$3.83K ﹤0.01%
201
MSTR icon
403
Strategy Inc
MSTR
$36B
$3.79K ﹤0.01%
60
MJ icon
404
Amplify Alternative Harvest ETF
MJ
$101M
$3.79K ﹤0.01%
98
LEN icon
405
Lennar Class A
LEN
$20.5B
$3.78K ﹤0.01%
26
CRSP icon
406
CRISPR Therapeutics
CRSP
$4.6B
$3.76K ﹤0.01%
60
MO icon
407
Altria Group
MO
$122B
$3.74K ﹤0.01%
93
+2
+2% +$83
EQH icon
408
Equitable Holdings
EQH
$13.3B
$3.73K ﹤0.01%
+112
New +$3.28K
CCI icon
409
Crown Castle
CCI
$32.4B
$3.67K ﹤0.01%
32
-33
-51% -$3.38K
CHWY icon
410
Chewy
CHWY
$8.93B
$3.66K ﹤0.01%
155
IRM icon
411
Iron Mountain
IRM
$37.8B
$3.66K ﹤0.01%
52
MACK
412
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$3.64K ﹤0.01%
272
PLTR icon
413
Palantir
PLTR
$315B
$3.61K ﹤0.01%
210
+50
+31% +$891
GLOB icon
414
Globant
GLOB
$1.41B
$3.57K ﹤0.01%
15
LMND icon
415
Lemonade
LMND
$4.76B
$3.56K ﹤0.01%
221
-276
-56% -$4.16K
DBX icon
416
Dropbox
DBX
$7.13B
$3.54K ﹤0.01%
120
SHW icon
417
Sherwin-Williams
SHW
$80.7B
$3.5K ﹤0.01%
11
ESGE icon
418
iShares ESG Aware MSCI EM ETF
ESGE
$6.53B
$3.48K ﹤0.01%
109
+3
+3% +$93
CEF icon
419
Sprott Physical Gold and Silver Trust
CEF
$7.49B
$3.35K ﹤0.01%
175
HNST icon
420
The Honest Company
HNST
$423M
$3.3K ﹤0.01%
1,000
CLDX icon
421
Celldex Therapeutics
CLDX
$2.8B
$3.29K ﹤0.01%
83
ELV icon
422
Elevance Health
ELV
$82.1B
$3.15K ﹤0.01%
7
BKF icon
423
iShares MSCI BIC ETF
BKF
$76.4M
$3.12K ﹤0.01%
91
+1
+1% +$34
ITT icon
424
ITT
ITT
$17.7B
$3.08K ﹤0.01%
26
CAG icon
425
Conagra Brands
CAG
$7.29B
$3.04K ﹤0.01%
106
+1
+1% +$28

Similar funds

Rise Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Rise Advisors held 677 positions worth $143M, up 13% from $126M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Rise Advisors's Q4 2023 filing shows 27 new, 219 increased, 106 reduced and 59 closed positions. Its largest new stake was Janus Henderson Mortgage-Backed Securities ETF: 217,780 shares worth $10M. The largest sale was Vanguard Growth ETF, an estimated $7.84M.

By sector, the portfolio is most concentrated in Financials at 5.8% of assets, up from 5.2% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Rise Advisors's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 217,780 shares worth $10M.
  • Rise Advisors added most to Vanguard Value ETF in Q4 2023, an estimated $948K increase.
  • Rise Advisors's biggest Q4 2023 reduction was Vanguard Growth ETF, cutting an estimated $7.84M.
  • Rise Advisors fully exited Becton Dickinson in Q4 2023, selling an estimated $75.2K.
  • Rise Advisors's ten largest holdings make up 73% of its $143M portfolio in Q4 2023.
  • Rise Advisors opened 27 new positions and closed 59 in Q4 2023.
  • Rise Advisors's portfolio value rose 13% quarter-over-quarter to $143M.

Based on Rise Advisors's 13F filing for Q4 2023, filed 10 Jan 2024.